Bank of Montreal
KPTI icon

Bank of Montreal’s Karyopharm Therapeutics KPTI Stock Holding History

Bank of Montreal’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36
Closed -$6K – 3886
2021
Q2 		$6K Sell
36
-100
-74% -$14.5K ﹤0.01% 3582
2021
Q1 		$21K Sell
136
-605
-82% -$127K ﹤0.01% 4031
2020
Q4 		$179K Buy
741
+524
+241% +$121K ﹤0.01% 3281
2020
Q3 		$47K Sell
217
-156
-42% -$38.2K ﹤0.01% 3463
2020
Q2 		$106K Buy
+373
New +$110K ﹤0.01% 3064
2020
Q1 		– Sell
-504
Closed -$145K – 4399
2019
Q4 		$145K Buy
504
+160
+47% +$34.7K ﹤0.01% 3326
2019
Q3 		$50K Buy
344
+26
+8% +$3.52K ﹤0.01% 3623
2019
Q2 		$29K Buy
+318
New +$25.5K ﹤0.01% 3950
2019
Q1 		– Sell
-45
Closed -$6K – 4532
2018
Q4 		$6K Buy
45
+23
+105% +$3.88K ﹤0.01% 4023
2018
Q3 		$6K Sell
22
-1
-4% -$276 ﹤0.01% 4072
2018
Q2 		$6K Buy
+23
New +$5.69K ﹤0.01% 4086
2017
Q3 		– Sell
-1,088
Closed -$148K – 4248
2017
Q2 		$148K Hold
1,088
– – ﹤0.01% 2804
2017
Q1 		$210K Hold
1,088
– – ﹤0.01% 2441
2016
Q4 		$151K Hold
1,088
– – ﹤0.01% 2628
2016
Q3 		$159K Buy
+1,088
New +$131K ﹤0.01% 2542
2016
Q2 		– Sell
-20
Closed -$3K – 4212
2016
Q1 		$3K Sell
20
-9
-31% -$993 ﹤0.01% 3915
2015
Q4 		$6K Buy
29
+23
+383% +$4.98K ﹤0.01% 3747
2015
Q3 		$1K Buy
6
+1
+20% +$267 ﹤0.01% 3875
2015
Q2 		$2K Hold
5
– – ﹤0.01% 3753
2015
Q1 		$2K Hold
5
– – ﹤0.01% 3786
2014
Q4 		$3K Buy
+5
New +$2.84K ﹤0.01% 3779
2014
Q3 		– Sell
-13
Closed -$9K – 4215
2014
Q2 		$9K Buy
+13
New +$6.05K ﹤0.01% 3919

Other funds holding KPTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's KPTI Position: Q3 2021 in Review

Bank of Montreal sold out of Karyopharm Therapeutics (KPTI) in Q3 2021, closing a stake of 36 shares — an estimated $6K sold.

Bank of Montreal first reported a position in KPTI in Q2 2014 and held it in 22 quarters. The position peaked at $210K in Q1 2017. 134 funds tracked by Wall St. Rank hold KPTI as of Q3 2021.

  • Bank of Montreal reported no remaining Karyopharm Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Bank of Montreal sold 36 Karyopharm Therapeutics shares in Q3 2021, an estimated $6K.
  • Bank of Montreal first reported a position in Karyopharm Therapeutics in Q2 2014 and held it in 22 quarters.
  • Bank of Montreal's Karyopharm Therapeutics position peaked at $210K in Q1 2017.
  • 134 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2021.

Based on Bank of Montreal's 13F filing for Q3 2021, filed 12 Nov 2021.